Dashboard
Manage Tickers

RNXT RenovoRx, Inc.

Nasdaq www.renovorx.com


$ 1.32 $ 0.20 (18.35 %)    

Wednesday, 15-Oct-2025 19:59:37 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 602.61 $ 4.22 (0.71 %)
DIA $ 463.04 $ 0.00 (0 %)
SPY $ 665.11 $ 2.94 (0.44 %)
TLT $ 90.76 $ -0.20 (-0.22 %)
GLD $ 387.41 $ 6.60 (1.73 %)
$ 1.29
$ 1.11
$ 1.17 x 20
$ 1.33 x 200
$ 1.10 - $ 1.30
$ 0.75 - $ 1.69
843,145
na
47.27M
$ 1.27
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-14-2025 06-30-2025 10-Q
2 05-15-2025 03-31-2025 10-Q
3 04-01-2025 12-31-2024 10-K
4 11-13-2024 09-30-2024 10-Q
5 08-13-2024 06-30-2024 10-Q
6 05-10-2024 03-31-2024 10-Q
7 04-01-2024 12-31-2023 10-K
8 11-13-2023 09-30-2023 10-Q
9 08-16-2023 06-30-2023 10-Q
10 05-12-2023 03-31-2023 10-Q
11 03-31-2023 12-31-2022 10-K
12 11-14-2022 09-30-2022 10-Q
13 08-12-2022 06-30-2022 10-Q
14 05-13-2022 03-31-2022 10-Q
15 03-30-2022 12-31-2021 10-K
16 11-15-2021 09-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

renovorx-completes-first-registry-eligible-patient-procedure-in-panther-post-marketing-registry-study-at-university-of-vermont-cancer-center
RenovoRx Completes First Registry-Eligible...
09/25/2025 12:32:53

First Registry-Eligible Patient Procedure Commenced at the University of Vermont Cancer CenterBaptist Health Miami Cancer Insti...

top-4-biotech-stocks-set-for-a-breakout-momentum-scores-surge
Top 4 Biotech Stocks Set For A Breakout: M...
09/08/2025 09:59:39

Several biotech stocks are showing renewed strength over the past week, with their Momentum scores soaring in Benzinga's Ed...

Core News & Articles
12 Health Care Stocks Moving In Friday's I...
08/15/2025 17:07:19

Core News & Articles
12 Health Care Stocks Moving In Friday's P...
08/15/2025 12:10:02

renovorx-announces-the-independent-data-monitoring-committee-for-its-ongoing-phase-iii-tiger-pac-trial-has-recommended-to-continue-the-study
RenovoRx Announces The Independent Data Mo...
08/14/2025 20:18:54

"At the same time, we are very excited to report that the independent Data Monitoring Committee (DMC) for our ongoing Phase...

renovorx-q2-eps-008-beats-009-estimate-sales-42200k-beat-32967k-estimate
RenovoRx Q2 EPS $(0.08) Beats $(0.09) Esti...
08/14/2025 20:12:52

RenovoRx (NASDAQ:RNXT) reported quarterly losses of $(0.08) per share which beat the analyst consensus estimate of $(0.09) by 8...

Core News & Articles
Earnings Scheduled For August 14, 2025
08/14/2025 08:32:32

renovorx-expands-renovocath-commercial-reach-to-13-cancer-centers
RenovoRx Expands RenovoCath Commercial Rea...
08/06/2025 12:38:18

RenovoRx increases its commercial footprint to thirteen leading National Cancer Institute-designated and community centers appr...

renovorx-launches-panther-post-marketing-registry-study-to-expand-safety-and-performance-data-of-fda-cleared-renovocath-device-and-associated-survival-outcomes-in-patients-diagnosed-with-solid-tumors
RenovoRx Launches PanTheR Post-Marketing R...
07/28/2025 12:36:50

Several Esteemed Cancer Centers to Commence Patient Enrollment Before the End of SeptemberThe Registry Study, Known as PanTheR,...

Core News & Articles
12 Health Care Stocks Moving In Friday's A...
06/27/2025 21:05:51

ascendiant-capital-maintains-buy-on-renovorx-raises-price-target-to-115
Ascendiant Capital Maintains Buy on Renovo...
06/05/2025 10:33:44

Ascendiant Capital analyst Edward Woo maintains RenovoRx (NASDAQ:RNXT) with a Buy and raises the price target from $11 to $1...

hc-wainwright--co-reiterates-buy-on-renovorx-maintains-3-price-target
HC Wainwright & Co. Reiterates Buy on Reno...
05/19/2025 10:52:43

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates RenovoRx (NASDAQ:RNXT) with a Buy and maintains $3 price t...

renovorx-q1-eps-008-beats-009-estimate-sales-19700k-miss-22500k-estimate
RenovoRx Q1 EPS $(0.08) Beats $(0.09) Esti...
05/15/2025 20:07:04

RenovoRx (NASDAQ:RNXT) reported quarterly losses of $(0.08) per share which beat the analyst consensus estimate of $(0.09) by 1...

Core News & Articles
Earnings Scheduled For May 15, 2025
05/15/2025 08:32:23

earnings-preview-for-renovorx
Earnings Preview For RenovoRx
05/14/2025 15:01:47

renovorx-secures-new-us-patent-for-renovorx-novel-trans-arterial-micro-profusion-therapy-platform
RenovoRx Secures New U.S. Patent For Renov...
05/06/2025 12:34:59

Patent Expands Protection of TAMP therapy platform, Including Methods to Deliver an Agent, such as a Chemotherapeutic Drug, Nea...

johns-hopkins-medicine-initiates-enrollment-for-renovorxs-ongoing-phase-iii-tiger-pac-clinical-trial
Johns Hopkins Medicine Initiates Enrollmen...
04/29/2025 12:37:33

Johns Hopkins Medicine's Valerie Lee, MD joins Michael J. Pishvaian, MD in an Appointed Key Role for TIGeR-PaC TrialBy beco...

ascendiant-capital-maintains-buy-on-renovorx-raises-price-target-to-11
Ascendiant Capital Maintains Buy on Renovo...
04/28/2025 11:16:42

Ascendiant Capital analyst Edward Woo maintains RenovoRx (NASDAQ:RNXT) with a Buy and raises the price target from $9 to $11.

renovorx-increases-us-production-of-renovocath-devices-to-meet-growing-demand-from-oncology-community-devices-made-at-facility-in-north-barrington-illinois
RenovoRx Increases U.S. Production Of Reno...
04/16/2025 12:34:13

RenovoCath is proudly made in America at a facility in North Barrington, ILRenovoRx management and board members purchased over...

12-health-care-stocks-moving-in-mondays-after-market-session
12 Health Care Stocks Moving In Monday's A...
04/07/2025 21:05:55

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION